Plexxikon completes $27mm Series B round; gets another $15mm
Executive Summary
Small-molecule drug discovery start-up Plexxikon raised $27mm in a Series B private placement to lead investor Walden International. Also participating in the round were other new investors GIMV and AM Pappas, along with return investors Alta Partners, CW Group, Advanced Technology Ventures, and Kumho Group.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Technologies
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice